Michele M. Maxwell

Statistics

Publications

Citations

2.6K

H-Index

Active since

1993

Affiliations

Massachusetts General Hospital(Current)

Harvard University

MaineGeneral Medical Center

École Polytechnique Fédérale de Lausanne

University of California, Irvine

Michele M. Maxwell is an author at Massachusetts General Hospital specializing in life sciences, molecular neuroscience, and neurodegenerative disorders.

Publications per year

1993–2016

Publications

Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

Tiago F. Outeiro, Eirene Kontopoulos, Stephen M. Altmann et al. · Science · 2007 · 1.1K citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis

Ruth Luthi‐Carter, David Taylor, Judit Pallos et al. · Proceedings of the National Academy of Sciences · 2010 · 340 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseases

Ruth A. Bodner, Tiago F. Outeiro, Stephen M. Altmann et al. · Proceedings of the National Academy of Sciences · 2006 · 258 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration <i>in vivo</i>

Xiaoqian Zhang, Donna L. Smith, Anatoli B. Meriin et al. · Proceedings of the National Academy of Sciences · 2005 · 247 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS

Michele M. Maxwell, Elizabeth M. Tomkinson, Johnathan Nobles et al. · Human Molecular Genetics · 2011 · 205 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15

1–5 of 13